Balance Sheet - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 219.85 | 245.48 | 281.80 | 330.39 | 384.06 | 36.09 | 0.08 |
| Accounts receivable, net | 1.68 | 1.26 | 1.43 | 1.12 | 0.11 | 0.01 | |
| Inventories | -1.12 | 1.25 | 0.11 | ||||
| Other current assets | 2.26 | 1.30 | 1.35 | 3.62 | 1.26 | 0.13 | 0.01 |
| Total current assets | 223.78 | 248.04 | 284.58 | 335.12 | 385.44 | 36.23 | 0.09 |
| Total non-current assets | 2.42 | 4.05 | 5.06 | 6.02 | 5.12 | 0.28 | 0.00 |
| Total assets | 226.20 | 252.09 | 289.64 | 341.14 | 390.56 | 36.52 | 0.09 |
| Total current liabilities | 13.06 | 8.46 | 9.62 | 10.78 | 5.28 | 2.33 | 3.73 |
| Total non-current liabilities | 0.65 | 1.53 | 2.33 | 3.05 | 3.14 | 45.50 | 0.00 |
| Total liabilities | 13.70 | 10.00 | 11.96 | 13.83 | 8.43 | 47.83 | 3.73 |
| Total stockholders' equity | 212.50 | 242.10 | 277.69 | 327.31 | 382.13 | -11.32 | -3.64 |
| Common shares outstanding | 57 | 57 | 56 | 56 | 46 | 27 | 27 |
Show Quarterly Balance Sheet
Balance Sheet - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 222.82 | 219.85 | 205.97 | 216.28 | 229.67 | 245.48 | 254.07 | 261.02 | 270.69 | 281.80 | 290.94 | 303.09 | 315.39 | 330.39 | 344.23 | 359.38 | 371.22 | 384.06 | 393.72 | 402.84 | 411.34 | 36.09 | 0.00 | 0.00 | 0.08 |
| Accounts receivable, net | 1.82 | 1.68 | 1.38 | 1.35 | 1.41 | 1.26 | 1.18 | 1.40 | 1.68 | 1.43 | 1.21 | 0.99 | 0.97 | 1.12 | 0.75 | 0.69 | 0.10 | 0.11 | 0.05 | 0.08 | 0.03 | 0.01 | |||
| Inventories | -1.21 | -0.99 | -0.97 | -1.12 | 1.42 | 2.44 | -0.11 | 0.11 | |||||||||||||||||
| Other current assets | 2.40 | 2.26 | 1.68 | 2.17 | 2.57 | 1.30 | 1.99 | 2.43 | 1.52 | 1.35 | 2.40 | 1.96 | 2.57 | 3.62 | 3.51 | 1.65 | 2.55 | 1.26 | 1.53 | 1.96 | 0.39 | 0.13 | |||
| Total current assets | 227.05 | 223.78 | 209.03 | 219.79 | 233.64 | 248.04 | 257.24 | 264.84 | 273.89 | 284.58 | 294.54 | 306.05 | 318.94 | 335.12 | 348.49 | 361.72 | 373.87 | 385.44 | 395.29 | 404.88 | 411.75 | 36.23 | 0.08 | ||
| Total non-current assets | 3.39 | 2.42 | 2.74 | 3.09 | 3.83 | 4.05 | 4.39 | 4.74 | 4.91 | 5.06 | 5.33 | 5.59 | 5.80 | 6.02 | 6.08 | 6.21 | 4.93 | 5.12 | 5.06 | 0.27 | 0.10 | 0.28 | -0.08 | ||
| Total assets | 230.44 | 226.20 | 211.77 | 222.89 | 237.48 | 252.09 | 261.63 | 269.58 | 278.79 | 289.64 | 299.87 | 311.63 | 324.74 | 341.14 | 354.57 | 367.93 | 378.80 | 390.56 | 400.35 | 405.15 | 411.85 | 36.52 | |||
| Total current liabilities | 10.19 | 13.06 | 11.17 | 8.75 | 8.24 | 8.46 | 7.43 | 6.39 | 7.09 | 9.62 | 12.39 | 12.13 | 9.05 | 10.78 | 10.41 | 7.39 | 5.48 | 5.28 | 5.51 | 3.41 | 3.71 | 2.33 | |||
| Total non-current liabilities | 2.20 | 0.65 | 0.88 | 1.10 | 1.32 | 1.53 | 1.74 | 1.95 | 2.14 | 2.33 | 2.52 | 2.70 | 2.88 | 3.05 | 3.22 | 3.38 | 3.01 | 3.14 | 3.28 | 0.14 | 0.14 | 45.50 | |||
| Total liabilities | 12.39 | 13.70 | 12.05 | 9.85 | 9.56 | 10.00 | 9.18 | 8.34 | 9.24 | 11.96 | 14.91 | 14.84 | 11.93 | 13.83 | 13.63 | 10.77 | 8.49 | 8.43 | 8.79 | 3.55 | 3.85 | 47.83 | |||
| Total stockholders' equity | 218.05 | 212.50 | 199.72 | 213.04 | 227.92 | 242.10 | 252.45 | 261.24 | 269.56 | 277.69 | 284.96 | 296.80 | 312.82 | 327.31 | 340.94 | 357.16 | 370.31 | 382.13 | 391.56 | 401.60 | 408.01 | -11.32 | -3.64 | ||
| Common shares outstanding | 61 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 55 | 18 | 27 | 27 | 27 | 27 |